U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974916) titled 'EMBRACE Tremor BiFUS' on May 07.

Brief Summary: This is a post-market (Phase IV) randomized, controlled, blinded, multicenter study with the aim to determine the added value of staged bilateral Exablate thalamotomy compared to a group of patients on previous unilateral treatment combined with local standard medical treatment.

Study Start Date: March 11

Study Type: INTERVENTIONAL

Condition: Essential Tremor

Intervention: PROCEDURE: Staged bilateral Exablate thalamotomy

Staged bilateral Exablate thalamotomy in ET patients

OTHER: Local standard medical treatment after previous Exablate unilateral thalamotomy.

Local standard med...